Topotecan for Relapsed Small-cell Lung Cancer: Systematic Review and Meta-Analysis of 1347 Patients - Horita, Nobuyuki; Yamamoto, Masaki; Sato, Takashi; Tsukahara, Toshinori; Nagakura, Hideyuki; Tashiro, Ken; Shibata, Yuji; Watanabe, Hiroki; Nagai, Kenjiro; Inoue, Miyo; Nakashima, Kentaro; Ushio, Ryota; et al. (Scientific Reports, 2015)
Keywords: 692/308/409; Anemia; Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Combined Chemotherapy Protocols - adverse effects; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Chemotherapy; Data processing; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions; Drug-Related Side Effects and Adverse Reactions - epidemiology; Drug-Related Side Effects and Adverse Reactions - pathology; Humanities and Social Sciences; Humans; Lung cancer; Lung carcinoma; Meta-analysis; multidisciplinary; Neoplasm Recurrence, Local; Neoplasm Recurrence, Local - drug therapy; Neoplasm Recurrence, Local - epidemiology; Neoplasm Recurrence, Local - pathology; Neutropenia; Response rates; Science; Side effects; Small Cell Lung Carcinoma; Small Cell Lung Carcinoma - drug therapy; Small Cell Lung Carcinoma - epidemiology; Small Cell Lung Carcinoma - pathology; Thrombocytopenia; Topotecan; Topotecan - adverse effects; Topotecan - therapeutic use